New SEC Form D filing

Theradaptive, Inc., 2026-08-04

A new SEC Form D private-offering notice from Frederick, MD, a $77,925,166 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Theradaptive, Inc. site↗ Verified via SEC Form D

Biopharmaceutical company developing a protein engineering platform that delivers therapeutic proteins for regenerative applications including spinal fusion, orthopedics, and soft tissue repair

Filed 2026-08-04Filed to raise $77,925,166First money in 2026-07-21Raised so far $36,156,177HQ (as filed) Frederick, MDSector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified theradaptive.com↗Named in the filing 7 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source